中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
23期
146-147
,共2页
慢性%重型%病毒性肝炎%恩替卡韦%效果
慢性%重型%病毒性肝炎%恩替卡韋%效果
만성%중형%병독성간염%은체잡위%효과
Chronic%Heavy duty%Viral hepatitis%Entecavir%Effect
目的 评价慢性重型乙型病毒性肝炎应用恩替卡韦治疗的临床效果.方法 选取我院2012年8月~2014年5月收治的50例慢性重型乙型病毒性肝炎患者作为观察对象,随机分成对照组与实验组,各25例.对照组采用传统的常规治疗,实验组在对照组基础之上加用恩替卡韦进行治疗,观察治疗后的临床疗效.结果 对照组治疗后临床疗效的总有效率为60%,实验组治疗后临床疗效的总有效率为84%,实验组的临床疗效高于对照组,P<0.05,差异具有统计学意义.结论 慢性重型乙型病毒性肝炎患者应用恩替卡韦治疗的效果显著.
目的 評價慢性重型乙型病毒性肝炎應用恩替卡韋治療的臨床效果.方法 選取我院2012年8月~2014年5月收治的50例慢性重型乙型病毒性肝炎患者作為觀察對象,隨機分成對照組與實驗組,各25例.對照組採用傳統的常規治療,實驗組在對照組基礎之上加用恩替卡韋進行治療,觀察治療後的臨床療效.結果 對照組治療後臨床療效的總有效率為60%,實驗組治療後臨床療效的總有效率為84%,實驗組的臨床療效高于對照組,P<0.05,差異具有統計學意義.結論 慢性重型乙型病毒性肝炎患者應用恩替卡韋治療的效果顯著.
목적 평개만성중형을형병독성간염응용은체잡위치료적림상효과.방법 선취아원2012년8월~2014년5월수치적50례만성중형을형병독성간염환자작위관찰대상,수궤분성대조조여실험조,각25례.대조조채용전통적상규치료,실험조재대조조기출지상가용은체잡위진행치료,관찰치료후적림상료효.결과 대조조치료후림상료효적총유효솔위60%,실험조치료후림상료효적총유효솔위84%,실험조적림상료효고우대조조,P<0.05,차이구유통계학의의.결론 만성중형을형병독성간염환자응용은체잡위치료적효과현저.
Objective To evaluate clinical effect of application entecavir in treatment chronic severe hepatitis B viral. Methods Selected 50 cases of chronic severe hepatitis B from August 2012 to May 2014 in our hospital as research object, randomly divided into the control group and the experimental group, each group had 25 cases, the control group adopt traditional regular treatment, the experimental group based on the control group with entecavir treatment, observed the clinical curative effect of two groups.Results After treatment the control group total effective rate was 60%, the experimental group total effective rate was 84%, the clinical effect of the experimental group was higher than the control group,P<0.05, had difference statistically signiifcance.Conclusion Entecavir treatment effect is remarkable to application in chronic severe hepatitis B patients.
